Related Experiment Video
Updated: Nov 15, 2025

Detection of Fluorescent Nanoparticle Interactions with Primary Immune Cell Subpopulations by Flow Cytometry
Published on: March 28, 2014
Development of a nanotechnology-based approach for capturing and detecting nucleic acids by using flow cytometry
Agustín Robles-Remacho1, M Angélica Luque-González1, Roberto A González-Casín2
1GENYO. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS Granada, Avenida de La Ilustracion, 114, 18016, Granada, Spain; Department of Medicinal and Organic Chemistry, School of Pharmacy, University of Granada, Campus Cartuja S/n, 18071, Granada, Spain; Biosanitary Research Institute of Granada (ibs.GRANADA), University Hospital of Granada/University of Granada, Avenida Del Conocimiento, S/n, 18016, Granada, Spain.
This study introduces a novel nanotechnology and dynamic chemical labeling (DCL) method for precise nucleic acid detection. The system offers a low-cost, easy-to-use platform for diagnosing genetic diseases and infectious outbreaks.
Area of Science:
- Molecular Biology
- Nanotechnology
- Biotechnology
Background:
- Nucleic acid diagnostics are crucial for genetic disease detection and infectious disease outbreak management.
- Developing cost-effective and user-friendly nucleic acid analysis systems is a significant challenge.
- Existing methods may lack the resolution or accessibility required for widespread clinical application.
Purpose of the Study:
- To develop an innovative, low-cost, and user-friendly system for nucleic acid detection and analysis.
- To combine nanotechnology with dynamic chemical labeling (DCL) for single-base resolution nucleic acid reading.
- To establish a proof-of-concept assay for detecting clinically relevant mutations, specifically in KRAS codon 12.
Main Methods:
- Integration of a nanotechnology-based approach with dynamic chemical labeling (DCL) technology.
- Development of a system capable of detecting biotinylated molecular products.
- Utilizing a standard flow cytometer for simple and widely accessible detection.
Main Results:
- The combined system achieves single-base resolution in nucleic acid analysis.
- The assay successfully detects mutations in KRAS codon 12, a key factor in cancer.
- The method demonstrates ease of implementation using a standard flow cytometer.
Conclusions:
- The developed nanotechnology-DCL system provides a powerful tool for nucleic acid-based molecular diagnostics.
- This approach offers a cost-effective and accessible solution for detecting genetic mutations and managing disease outbreaks.
- The system's compatibility with standard laboratory equipment facilitates its clinical translation.

